MedTrace Logo

Clinical Evaluation of Rapid RNA Test for Covid-19

NCT05308550 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 369

Last updated 2022-04-04

No results posted yet for this study

Summary

A new Rapid RNA test for Covid-19 has been developed by Professor Cui and his team at the Department of Engineering Science at the University of Oxford. This can give results in 30 minutes which is much faster than the routine PCR test, which often takes 2-3 days to produce results. In this study we aim to establish the sensitivity of the rapid RNA test, which has never before been evaluated clinically. Preliminary anecdotal evidence suggests that the test is easy to use and appears to give valid results. This initial trial aims to establish whether the sensitivity of this tests is above the threshold of 90%. We aim to include at least 173 patients with symptoms of Covid-19 in Watford General Hospital.

Conditions

Interventions

DIAGNOSTIC_TEST

rapid RT-LAMP test to detect SARS-COV-2 RNA

rapid RT-LAMP test to detect SARS-COV-2 RNA

Sponsors & Collaborators

  • West Hertfordshire Hospitals NHS Trust

    collaborator OTHER

  • University of Oxford

    collaborator OTHER

  • University of Southampton

    lead OTHER

Principal Investigators

  • Michael Moore, FRCGP · University of Southampton

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-27
Primary Completion
2021-02-27
Completion
2021-02-27

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05308550 on ClinicalTrials.gov